ZELIRA THERAPEUTICS
Zelira Therapeutics Ltd is a leading global therapeutic medicinal cannabis company with access to the world’s largest and fastest growing cannabis markets.
ZELIRA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2003-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.zeliratx.com
Total Employee:
1+
Status:
Active
Contact:
+61 8 6558 0886
Email Addresses:
[email protected]
Total Funding:
13.2 M USD
Technology used in webpage:
Google Maps CrUX Top 50m CrUX Dataset Twenty Twenty
Similar Organizations
Afrobodies
Afrobodies is a South African recombinant alpaca antibody production company.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Genomics
Genomics plc aiming to lead the genomic transformation of healthcare.
Peloton Advantage
Peloton Advantage is a privately owned medical communications company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-24 | Health House | Health House acquired by Zelira Therapeutics | N/A |
Investors List
Cantheon Capital
Cantheon Capital investment in Post-IPO Equity - Zelira Therapeutics
Official Site Inspections
http://www.zeliratx.com Semrush global rank: 6.6 M Semrush visits lastest month: 1.05 K
- Host name: 145.160.247.35.bc.googleusercontent.com
- IP address: 35.247.160.145
- Location:
- Latitude: 35
- Longitude: 105
- Timezone: Australia/Perth
More informations about "Zelira Therapeutics"
Zelira Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +61 8 6558 0886 Zelira Therapeutics Ltd is a leading global therapeutic medicinal cannabis company with access to the world’s largest …See details»
Who is Zelira? – Zelira Therapeutics
We’re a global biopharmaceutical company positioned to access the world’s largest and fastest growing cannabinoid medicine markets. Zelira Therapeutics is passionate about ethical medicine and committed to world class science and …See details»
Board – Zelira Therapeutics
Dr. Donna Gentile O’Donnell, a highly regarded health care executive, most recently (May, 2023) served as special assistant to Dr. Stephen K. Klasko, former president of Thomas Jefferson University and CEO of Jefferson Health, and …See details»
Zelira Therapeutics - LinkedIn
Zelira Therapeutics Biotechnology Research Perth, Western Australia 2,544 followers Zelira Therapeutics (formerly Zelda Therapeutics) is a leading global therapeutic medicinal cannabis …See details»
Zelira Therapeutics Limited (ZLDAF)
See the company profile for Zelira Therapeutics Limited (ZLDAF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Zelira Therapeutics Company Description - Stock Analysis
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a …See details»
Zelira Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Zelira Therapeutics - Developer of cannabis-based therapeutics for multiple diseases. Public Company. Raised funding over 6 rounds from 2 investors. Zelira …See details»
Zelira expands geographical footprint and progresses For personal …
Oct 31, 2022 Zelira Therapeutics Level 3, 101 St Georges Terrace, Perth WA 6000 Phone +61 8 6558 0886 zeliratx.com. Zelira has developed Enhanced Distillate Capture and Dissolution …See details»
Investors – Zelira Therapeutics
Gain access to the world’s largest and fastest growing cannabinoid medicines markets. Zelira Therapeutics offers investors exposure to a rapidly growing global industry at a very attractive valuation with significant value drivers.See details»
Zelira Therapeutics - Overview, News & Similar companies
Nov 8, 2023 www.zeliratx.com. Revenue <$5 Million. Stock Symbol G1G.F. Industry Pharmaceuticals Healthcare . Recent News & Media. It's Unlikely That The CEO Of Zelira …See details»
Zelira secures US$8.6 million cornerstone funding for For personal …
Www.zeliratx.com ACN 103 782 378 USA 5110 Campus Drive, Suite 150 Plymouth Meeting, PA 19462 United States Of America +1 484-630-0650 Zelira Therapeutics Ltd (ASX:ZLD, …See details»
Zelira delivers strong Q3 with strategic For personal use only
Apr 29, 2022 Zelira Therapeutics Level 3, 101 St Georges Terrace, Perth WA 6000 Phone +61 8 6558 0886 zeliratx.com QUARTERLY ACTIVITIES REPORT FOR Q3 FY2022 ASX …See details»
Zelira Therapeutics Ltd, G1G:DUS profile - FT.com - Financial Times
2 days ago Year on year Zelira Therapeutics Ltd 's revenues fell -82.72% from 551.26k to 95.26k. This along with an increase in selling, general and administrative costs has contributed …See details»
Corporate Governance – Zelira Therapeutics
Corporate Governance Download corporate governance statements and policies below. Download Corporate Governance Statement: Corporate Governance StatementSee details»
Zelira to present at Automic Invest 2024 conference
[email protected] Investors Gabriella Hold Executive Director, Automic Group +61 411 364 382 [email protected] Australia Level 3, 101 St Georges Terrace …See details»
Oludare Odumosu | Global Managing Director and CEO - Zelira ...
Sep 10, 2021 Oludare ("Dare") Odumosu, PhD, is the CEO of a global cannabis formulation and research company Zelira Therapeutics, which recently made history with the world’s first …See details»
Presentations & Reports – Zelira Therapeutics
Nov 22, 2024 Osagie Imasogie (Chairman) and Oludare Odumosu (Global CEO) take investors and analysts through the top line comparative trial results of Zelira’s diabetic nerve pain drug …See details»
Zelira Completes Enrolment for Diabetic Nerve Pain Drug Trial
Zelira Therapeutics Level 3, 101 St Georges Terrace, Perth WA 6000 Phone +61 8 6558 0886 zeliratx.com The IRB approved trial has been designed as a multi arm head-to-head against a …See details»
Partnering – Zelira Therapeutics
Executive Director – Global Head of Commercial and Partnering at [email protected]. BACK TO THE TOP. Reimagine cannabinoid-based medicine with us. At Zelira we’re committed to …See details»